Overview

Womens Health Diagnostics Market is poised to value USD 45931.59 million by 2028 end at a CAGR of 7.9% during the forecast period 2022 to 2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Womens Health Diagnostics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Womens Health Diagnostics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Womens Health Diagnostics Market:
• Siemens AG
• Quest Diagnostics Inc.
• Hologic, Inc.
• F. Hoffmann-La Roche AG
• Perkinelmer Inc.
• Alere Inc.
• GE Healthcare
• Becton, Dickinson and Company
• Abbott Laboratories
• Biomérieux SA
• Koninklijke Philips N.V.
• Carestream Health
• Cardinal Health
• Siemens AG
• MedGyn Products, Inc.
• Cook Medical Incorporated
• Thermo Fisher Scientific
(Note: The list of the major players will be updated with the latest market scenario and trends)

Womens Health Diagnostics Market Segmentation:

By Application
• Breast Cancer Testing
  o Mammography Systems
  o Breast Cancer Tumor Marker Tests
  o Blood Chemistries and Blood Cell Count
  o Biopsies
  o Other Diagnostic Imaging Tests
• Infectious Disease Testing
  o Urinary Tract Infection Testing
  o MRSA Testing
  o Hepatitis Testing
  o Tuberculosis Testing
  o Other Infectious Disease Testing
• Cervical Cancer Testing
  o Pap Smear
  o HPV Testing
• Osteoporosis Testing
  o Bone Densitometry
  o In Vitro Blood Tests
• Sexually Transmitted Disease Testing
  o Chlamydia Trachomatis And Neisseria Gonorrhoeae (Ct/Ng) Testing
  o HIV Testing
 o Other Sexually Transmitted Diseases
• Prenatal Genetic Screening and Carrier Testing
  o Cystic Fibrosis
  o Down Syndrome and Edward Syndrome
  o TORCH Infections
  o Other Diseases
• Ultrasound
  o OB/GYN Imaging
  o Breast Imaging
• Pregnancy and Fertility Testing
  o Pregnancy Testing and Ovulation Prediction Kits
  o Lab-based Testing
  o Fertility Monitors
• Ovarian Cancer Testing
  o Ovarian Cancer Tumor Marker Tests
  o Diagnostic Imaging Tests
  o Other Tests

By End-User
• Hospitals and Diagnostic and Imaging Centerss
• Diagnostic and Imaging Centers
• Home Care

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Womens Health Diagnostics Market By Application, By End-User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Global Womens Health Diagnostics Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Application Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Womens Health Diagnostics Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Womens Health Diagnostics Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Application Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Application Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Global Womens Health Diagnostics Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
  7.1. Breast Cancer Testing
        7.1.1. Mammography Systems
        7.1.2. Breast Cancer Tumor Marker Tests
        7.1.3. Blood Chemistries and Blood Cell Count
        7.1.4. Biopsies
        7.1.5. Other Diagnostic Imaging Tests
  7.2. Infectious Disease Testing
        7.2.1. Urinary Tract Infection Testing
        7.2.2. MRSA Testing
        7.2.3. Hepatitis Testing
        7.2.4. Tuberculosis Testing
        7.2.5. Other Infectious Disease Testing
  7.3. Cervical Cancer Testing
         7.3.1. Pap Smear
        7.3.2. HPV Testing
  7.4. Osteoporosis Testing
        7.4.1. Bone Densitometry
        7.4.2. In Vitro Blood Tests
  7.5. Sexually Transmitted Disease Testing
        7.5.1. Chlamydia Trachomatis And Neisseria Gonorrhoeae (Ct/Ng) Testing
        7.5.2. HIV Testing
        7.5.3. Other Sexually Transmitted Diseases
  7.6. Prenatal Genetic Screening and Carrier Testing
        7.6.1. Cystic Fibrosis
        7.6.2. Down Syndrome and Edward Syndrome
        7.6.3. TORCH Infections
        7.6.4. Other Diseases
  7.7. Ultrasound
        7.7.1. OB/GYN Imaging
        7.7.2. Breast Imaging
  7.8. Pregnancy and Fertility Testing
        7.8.1. Pregnancy Testing and Ovulation Prediction Kits
        7.8.2. Lab-based Testing
        7.8.3. Fertility Monitors
  7.9. Ovarian Cancer Testing
        7.9.1. Ovarian Cancer Tumor Marker Tests
        7.9.2. Diagnostic Imaging Tests
        7.9.3. Other Tests

8. Global Womens Health Diagnostics Market, By End-User Historical Analysis and Forecast 2022-2028 (USD Million)  
  8.1. Hospitals and Diagnostic and Imaging Centerss
  8.2. Diagnostic and Imaging Centers
  8.3. Home Care

9. North America Womens Health Diagnostics Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
  9.1. Introduction
  9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
       9.2.1. U.S.A
       9.2.2. Canada
       9.2.3. Mexico
  9.3. Market Size (USD Million) Forecast for North America 2022-2028

10. Latin America Womens Health Diagnostics Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   10.1. Introduction
   10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         10.2.1. Brazil
         10.2.2. Venezuela
         10.2.3. Argentina
         10.2.4. Rest of Latin America
   10.3. Market Size (USD Million) Forecast for Latin America 2022-2028

11. Europe Womens Health Diagnostics Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   11.1. Introduction
   11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         11.2.1. Germany
         11.2.2. U.K        
         11.2.3. France
         11.2.4. Italy
         11.2.5. Spain
         11.2.6. Russia
         11.2.7. Poland
         11.2.8. Rest of Europe
   11.3. Market Size (USD Million) Forecast for Europe 2022-2028

12. Asia Pacific Womens Health Diagnostics Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   12.1. Introduction
   12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         12.2.1. Japan
         12.2.2. China
         12.2.3. India
         12.2.4. Australia and New Zealand
         12.2.5. ASEAN
         12.2.6. Rest of Asia Pacific
   12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

13. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         13.2.1. GCC
         13.2.2. Israel
         13.2.3. South Africa
         13.2.4. Rest of MEA
   13.3. Market Size (USD Million) Forecast for MEA 2022-2028

14. Market Share Analysis and Competitive Landscape  
   14.1. Global Landscape - Key Players, Revenue and Presence
   14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   14.3. Global Emerging Companies
   14.4.  North America - Market Share Analysis and Key Regional Players
   14.5.  Europe - Market Share Analysis and Key Regional Players
   14.6.  Asia Pacific - Market Share Analysis and Key Regional Players
   14.7.  Global Key Player - Growth Matrix

15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   15.1. Siemens AG
         15.1.1. Company Overview
         15.1.2. Product Portfolio
         15.1.3. SWOT Analysis
         15.1.4. Financial Overview
         15.1.5. Strategic Overview
   15.2. Quest Diagnostics Inc.
         15.2.1. Company Overview
         15.2.2. Product Portfolio
         15.2.3. SWOT Analysis
         15.2.4. Financial Overview
         15.2.5. Strategic Overview                        
   15.3. Hologic, Inc.
         15.3.1. Company Overview
         15.3.2. Product Portfolio
         15.3.3. SWOT Analysis
         15.3.4. Financial Overview
         15.3.5. Strategic Overview
   15.4. F. Hoffmann-La Roche AG
         15.4.1. Company Overview
         15.4.2. Product Portfolio
         15.4.3. SWOT Analysis
         15.4.4. Financial Overview
         15.4.5. Strategic Overview
   15.5. Perkinelmer Inc.
         15.5.1. Company Overview
         15.5.2. Product Portfolio
         15.5.3. SWOT Analysis
         15.5.4. Financial Overview
         15.5.5. Strategic Overview          
   15.6. Alere Inc.
         15.6.1. Company Overview
         15.6.2. Product Portfolio
         15.6.3. SWOT Analysis
         15.6.4. Financial Overview
         15.6.5. Strategic Overview      
   15.7. GE Healthcare
         15.7.1. Company Overview
         15.7.2. Product Portfolio
         15.7.3. SWOT Analysis
         15.7.4. Financial Overview
         15.7.5. Strategic Overview
   15.8. Becton, Dickinson and Company
         15.8.1. Company Overview
         15.8.2. Product Portfolio
         15.8.3. SWOT Analysis
         15.8.4. Financial Overview
         15.8.5. Strategic Overview
   15.9. Abbott Laboratories
         15.9.1. Company Overview
         15.9.2. Product Portfolio
         15.9.3. SWOT Analysis
         15.9.4. Financial Overview
         15.9.5. Strategic Overview
   15.10.Biomérieux SA        
         15.10.1. Company Overview
         15.10.2. Product Portfolio
         15.10.3. SWOT Analysis
         15.10.4. Financial Overview
         15.10.5. Strategic Overview
   15.11.Koninklijke Philips N.V.
         15.11.1. Company Overview
         15.11.2. Product Portfolio
         15.11.3. SWOT Analysis
         15.11.4. Financial Overview
         15.11.5. Strategic Overview
   15.12.Carestream Health
         15.12.1. Company Overview
         15.12.2. Product Portfolio
         15.12.3. SWOT Analysis
         15.12.4. Financial Overview
         15.12.5. Strategic Overview
   15.13.Cardinal Health
         15.13.1. Company Overview
         15.13.2. Product Portfolio
         15.13.3. SWOT Analysis
         15.13.4. Financial Overview
         15.13.5. Strategic Overview
   15.14.Siemens AG
         15.14.1. Company Overview
         15.14.2. Product Portfolio
         15.14.3. SWOT Analysis
         15.14.4. Financial Overview
         15.14.5. Strategic Overview
    15.15.MedGyn Products, Inc.
         15.15.1. Company Overview
         15.15.2. Product Portfolio
         15.15.3. SWOT Analysis
         15.15.4. Financial Overview
         15.15.5. Strategic Overview
   15.16.Cook Medical Incorporated
         15.16.1. Company Overview
         15.16.2. Product Portfolio
         15.16.3. SWOT Analysis
         15.16.4. Financial Overview
         15.15.5. Strategic Overview
   15.17.Thermo Fisher Scientific
         15.17.1. Company Overview
         15.17.2. Product Portfolio
         15.17.3. SWOT Analysis
         15.17.4. Financial Overview
         15.17.5. Strategic Overview
   
16. Pre and Post COVID-19 Impact
   16.1. Positive influence on the healthcare industry
   16.2. The financial disruption of the manufacturing sector
   16.3. Impact of COVID-19 on emerging companies
   16.4. Significant mandates in the healthcare regulations initiated by administrations
   16.5. The overall economic slowdown of the developing and developed nations

17. FutureWise SME Key Takeaway Points for Client

Tables

Figures